Ajooni Biotech (AJOONI)
Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹3.86 |
| Market Cap | ₹66.49 Cr |
| P/E Ratio | 15.44 |
| ROCE | 6.91% |
| ROE | 4.82% |
| Dividend Yield | 0% |
| Profit Growth | -44.74% |
| Debt/Equity | 0.19 |
| Sales Growth | 99.79% |
| Promoter Holding | 26.89% |
| 52-Week Range | ₹2.68 — ₹5.5 |
| Sector | Food Products |
| Book Value | ₹4.81 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
At ₹4.36, Ajooni’s market cap of ₹76 Cr is not much above my threshold for a meaningful position. It sells below book value — ₹5.53 per share — so on a Graham basis the asset cushion is there, and debt/equity of 0.11 is comfortable. The Piotroski F-Score of 7/9 points to improving fundamentals. But I never buy a business solely because it is cheap; the price must be justified by the long-term return on capital. Here ROE is just 5.51% and ROCE is 6.91%. That tells me management is not earning a superior return on what shareholders have entrusted to them. The latest quarter shows sales of ₹59 Cr and net profit of ₹2 Cr — a net margin around 3.4%. In animal feed, a commodity input business, such margins can evaporate quickly as raw material prices move or dairy economics turn against farmers.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer